Pricing Log in Create free account

Artelo Biosciences, Inc. (ARTL) vs Matinas Biopharma Holdings, Inc. (MTNB)

Artelo Biosciences, Inc. and Matinas Biopharma Holdings, Inc. are both Biotechnology companies. Artelo Biosciences, Inc. and Matinas Biopharma Holdings, Inc. are of similar size ($1.2M and $1.1M). Across the 11 metrics below, Matinas Biopharma Holdings, Inc. leads on 7 and Artelo Biosciences, Inc. on 4.

Valuation

Metric ARTL MTNB Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.12 9.40
P/B 0.12 0.30 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.33 0.04 0.66
EV/Sales n/m (0.06) 9.02
Earnings yield (10,336.94%) (1,403.30%) (32.88%)
Free cash flow yield (2,139.52%) (1,142.24%) (23.13%)

Profitability

Metric ARTL MTNB Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (705.71%) (154.28%) (51.96%)
Return on assets (234.30%) (98.53%) (46.06%)
Return on invested capital (865.85%) (419.27%) 0.00%

Growth

Metric ARTL MTNB Biotechnology median
Revenue growth (TTM) — 2,135.91% 6.76%
EPS growth (last fiscal year) 31.57% 59.84% 29.88%
Revenue growth, 5-year CAGR — 55.69% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARTL MTNB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.00 0.85 4.97
Net debt to EBITDA 0.05 0.62 1.01

Dividend

Metric ARTL MTNB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ARTL MTNB Biotechnology median
Market cap 1.16m 1.14m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack